Le Lézard
Classified in: Health
Subjects: HEALTH, MISCELLANEOUS

Canadian Metabolomic Technologies Secures $4.2M Series A Financing Round


EDMONTON, Alberta, Oct. 21, 2019 (GLOBE NEWSWIRE) -- Metabolomic Technologies Inc. (MTI), a Canadian-based company developing metabolomics-based in vitro diagnostics today announced the successful completion of a $4.2 million dollar Series A raise.

The Company's lead product, PolypDxtm, is the world's first and only urine test for colorectal cancer screening. Developed in Canada, and patented globally, PolypDxtm is currently being assessed by the Alberta provincial health system in Canada as a way to increase overall screening efforts to help manage the disease of colorectal cancer.

"This injection of capital supports our strategic initiatives and validates our ability to attract leading U.S. healthcare investors," stated Dr. David Chang, MTI's Chief Executive Officer. "While we anticipate the need to secure additional funds in the future, we are eager to achieve our goal to provide PolypDxtm to patients across the globe."   

"The support MTI has received from the investment community speaks to the strength of the Company's technology and award-winning leadership team," shared Dr. Randall Yatscoff, Chairman of the Board. "We are excited about this latest milestone and the momentum it creates in the advancement of PolypDxtm."

The next critical step to bring MTI's innovative test to patients, is a multi-centre pivotal trial in the United States. Evidence generated from the trial will provide the basis for a commercial launch, clinical acceptance and reimbursement of PolypDxtm.

About Metabolomic Technologies Inc.
Metabolomic Technologies Inc. (MTI) is a small but growing Canadian company developing metabolomic-based in vitro diagnostics. Their lead product, PolypDxtm is the first and only urine-based screening test for colorectal cancer. There are more than 40,000 small molecule metabolites found in the human body. Through the identification of distinct metabolic fingerprints, MTI is developing groundbreaking diagnostic tests. The company was awarded the Frost & Sullivan Technology Innovation Leadership Award, the ASTech Outstanding Leadership in Technology Award, and the BioAlberta Company of the Year Award.

MTI Contact
Jean Forsythe
Vice President, Corporate Development
Phone: 587.772.1684 ext. 2
jean.forsythe@metabolomictechnologies.ca
Websites: Metabolomic Technologies Inc. / PolypDxtm

Metabolomic Technologies Inc. legal disclaimer
This communication expressly or implicitly contains certain forward-looking statements concerning MTI and its business. Such statements involve certain known and unknown risks, uncertainties and other factors which could cause the actual results, financial condition, performance or achievements of MTI to be materially different from any expected results, performance or achievements expressed or implied by such forward-looking statements. MTI is providing this communication as of this date and does not undertake to update any forward-looking statements contained herein as a result of new information, future events or otherwise.


These press releases may also interest you

at 07:00
The Centrale des syndicats du Québec (CSQ) and its affiliated federations ? the Fédération des syndicats de l'enseignement , the Fédération du personnel de soutien scolaire (FPSS-CSQ), the Fédération des professionnelles et professionnels de...

at 00:00
The American Mission Hospital (AMH) has partnered up with Soza Health UK and Dhu3 to conduct health assessments in Bahrain. Under the theme 'Wellness in the workplace' ? Protecting your employees' it has launched the SOZA Health 'pilot' assessment...

at 00:00
With years of feedback from Orthopedics, Neurosurgeons, and Interventional pain physicians, Sacrix has developed the third iteration of the SacroFuse threaded compression device for immediate stabilization of the sacroiliac joint for pain relief and...

23 jan 2021
Despite concerns about both the COVID pandemic and political unrest, San Francisco pro-lifers held the 17th Annual Walk for Life West Coast today. Organizers had expected hundreds of attendees; thousands showed up. Walk co-chair Eva Muntean was...

23 jan 2021
The CEO of InterMed Resources TN, Roger Biles, adjusted his company's business structure in order to meet the exponential demands of personal protective equipment (PPE)....

23 jan 2021
The U.S. Small Business Administration (SBA) announced that Raptamer Discovery Group is one of only 38 companies, seven organizations and 14 individuals in the country to receive the prestigious Tibbetts Award for their accomplishments in creating...



News published on 21 october 2019 at 12:05 and distributed by: